AR and urogenital neoplasm: The HMG domain of WHSC1 can interact with the DNA-binding domain of the androgen receptor (AR) and, in the presence of the ligand, enhances AR-mediated transcriptional activation, thereby implicating WHSC1 in the promotion of prostate carcinogenesis (Kang et al., 2009).